EAN: 9780889376328

CLINICAL HANDBOOK OF PSYCHOTROPIC DRUGS

Quick and comprehensive information on psychotropic drugs for adults.  Accurate and up-to-date
Comparison charts help decision-making Icons with full color Available both in print and online
Downloadable patient information sheets  More about this book The Clinical Handbook of
Psychotropic Drugs has become a standard reference and working tool for psychiatrists 
psychologists  physicians  pharmacists  nurses  and other mental health professionals. 
Independent  unbiased  up-to-date Packed with unique  easy-to-read comparison charts and tables
(dosages  side effects  pharmacokinetics  interactions...) for a quick overview of treatment
options Succinct  bulleted information on all classes of medication: on- and off-label
indications  (US FDA  Health Canada)  recommended dosages  US and Canadian trade names  side
effects  interactions  pharmacodynamics  precautions in the young  the elderly  and pregnancy 
nursing implications  and much more - all you need to know for each class of drug Potential
interactions and side effects summarized in comparison charts With instantly recognizable icons
and in full color throughout  allowing you to find at a glance all the information you seek
Clearly written patient information sheets available for download as printable PDF files  This
book is a must for everyone who needs an up-to-date  easy-to-use  comprehensive summary of all
the most relevant information about psychotropic drugs. New in this edition  Antidepressants
chapter includes a new section on the NMDA receptor antagonist CYP2D6 inhibitor combination
product (dextromethorphan bupropion) Antipsychotics updates include revised clozapine
monitoring tables which now also contain monitoring requirements for patients with or without
non-benign ethnic neutropenia Mood Stabilisers sections on Lithium and Anticonvulsants
extensively revised Dementia chapter includes a new section on lecanemab  a new fast-track
FDA-approved treatment for Alzheimer's disease Treatment of Substance Use Disorders includes
revisions to buprenorphine dosing section that include a rapid micro-induction method (Bernese
method) that allows treatment to start without waiting for patient to be in withdrawal
Unapproved treatments of Psychiatric Disorders  Natural Health Products  and Pharmacogenetics
chapters all substantially revised New formulations and trade names include: Auvelity
(dextromethorphan bupropion extended-release tablets)  Invega Hafyera (paliperidone 6-monthly
IM injection)  Leqembi (lecanemab infusion)  Subutex (buprenorphine sublingual tablets) 
Quviviq (daridorexant tablets)

Aktuelle Preise zur EAN 9780889376328

Produktinformationen zur 9780889376328